Pfizer, BioNTech launch COVID-19 vaccine trial in kids under 12

Pfizer, BioNTech launch COVID-19 vaccine trial in kids under 12

Source: 
Yahoo/Reuters
snippet: 

Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the U.S. drugmaker said on Thursday.